Inovio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inovio and other ETFs, options, and stocks.

About INO

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. 

CEO
Jacqueline E. Shea
CEOJacqueline E. Shea
Employees
317
Employees317
Headquarters
Plymouth Meeting, Pennsylvania
HeadquartersPlymouth Meeting, Pennsylvania
Founded
1983
Founded1983
Employees
317
Employees317

INO Key Statistics

Market cap
431.46M
Market cap431.46M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
5.00M
Average volume5.00M
High today
$1.80
High today$1.80
Low today
$1.67
Low today$1.67
Open price
$1.69
Open price$1.69
Volume
3.57M
Volume3.57M
52 Week high
$7.77
52 Week high$7.77
52 Week low
$1.38
52 Week low$1.38

INO News

Simply Wall St 6d
Institutions along with individual investors who hold considerable shares inInovio Pharmaceuticals, Inc. come under pressure; lose 11% of holdings value - Yahoo Finance

A look at the shareholders of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) can tell us which group is most powerful. The group holding the most number of shares in...

Institutions along with individual investors who hold considerable shares inInovio Pharmaceuticals, Inc. come under pressure; lose 11% of holdings value - Yahoo Finance

Analyst ratings

86%

of 7 ratings
Buy
14.3%
Hold
85.7%
Sell
0%

INO Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8
ActualExpected Nov 8
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.